Preconditioning Involves Selective Mitophagy Mediated by Parkin and p62/SQSTM1 by Huang, Chengqun et al.
Preconditioning Involves Selective Mitophagy Mediated
by Parkin and p62/SQSTM1
Chengqun Huang
., Allen M. Andres
., Eric P. Ratliff, Genaro Hernandez, Pamela Lee, Roberta A. Gottlieb*
The BioScience Center, San Diego State University, San Diego, California, United States of America
Abstract
Autophagy-dependent mitochondrial turnover in response to cellular stress is necessary for maintaining cellular
homeostasis. However, the mechanisms that govern the selective targeting of damaged mitochondria are poorly
understood. Parkin, an E3 ubiquitin ligase, has been shown to be essential for the selective clearance of damaged
mitochondria. Parkin is expressed in the heart, yet its function has not been investigated in the context of cardioprotection.
We previously reported that autophagy is required for cardioprotection by ischemic preconditioning (IPC). In the present
study, we used simulated ischemia (sI) in vitro and IPC of hearts to investigate the role of Parkin in mediating
cardioprotection ex vivo and in vivo. In HL-1 cells, sI induced Parkin translocation to mitochondria and mitochondrial
elimination. IPC induced Parkin translocation to mitochondria in Langendorff-perfused rat hearts and in vivo in mice
subjected to regional IPC. Mitochondrial depolarization with an uncoupling agent similarly induced Parkin translocation to
mitochondria in cells and Langendorff-perfused rat hearts. Mitochondrial loss was blunted in Atg5-deficient cells, revealing
the requirement for autophagy in mitochondrial elimination. Consistent with previous reports indicating a role for p62/
SQSTM1 in mitophagy, we found that depletion of p62 attenuated mitophagy and exacerbated cell death in HL-1
cardiomyocytes subjected to sI. While wild type mice showed p62 translocation to mitochondria and an increase in
ubiquitination, Parkin knockout mice exhibited attenuated IPC-induced p62 translocation to the mitochondria. Importantly,
ablation of Parkin in mice abolished the cardioprotective effects of IPC. These results reveal for the first time the crucial role
of Parkin and mitophagy in cardioprotection.
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Introduction
Cellular homeostasis depends upon adequate protein and
organelle quality control. Cells have evolved selective clearance
mechanisms to eliminate misfolded and aggregated proteins or
dysfunctional organelles. Molecular chaperones in the heat shock
family of proteins facilitate the refolding of misfolded proteins.
Unrepaired misfolded proteins are ultimately targeted for
degradation by the ubiquitin-proteasome system (UPS) [1,2].
Elimination of larger dysfunctional complexes, aggregated proteins
or organelles such as mitochondria is accomplished via autophagy
[2,3,4,5].
Currently, there is great interest in determining how autophagy
can selectively recognize and remove damaged mitochondria.
Several groups have shown that in neuronal cells, Parkin is
involved in the selective targeting and degradation of damaged
mitochondria through autophagy (mitophagy) [5,6,7,8,9]. Loss of
mitochondrial membrane potential (DYm) stabilizes mitochondrial
outer membrane-associated protein PINK1, a kinase that signals
Parkin recruitment to the mitochondria [5,6,7]. Parkin is an E3
ubiquitin ligase found in the liver, kidneys, testis, brain, skeletal
muscle, and heart [10,11]. Under basal conditions, Parkin is
mainly found in the cytosol where its ubiquitin ligase activity is
inhibited by an unknown mechanism [6]. However, under
physiologic and pathologic stress, Parkin translocates to damaged
mitochondria in a PINK1-dependent manner to ubiquitinate
mitochondrial proteins such as VDAC1, Mfn1, Mfn2 and other
proteins [3,12,13,14].
Recently, p62/SQSTM1/sequestosome-1 (referred to as p62
hereafter) has been shown to bind ubiquitinated mitochondria
through its ubiquitin binding domain, and to recruit the
phagophore (cup-shaped early stage autophagosome) through an
LC3 binding domain [15,16,17,18]. Ablation of p62 has been
shown to attenuate the degradation of mitochondria compromised
by chemical uncouplers that dissipate the mitochondrial membrane
potential, revealing its role in mitophagy [3,19], although this is
controversial [20,21]. We previously reported that ischemic
preconditioning in isolated rat hearts mediates cardioprotection
against I/R injury through an autophagy-dependent pathway
involving p62 recruitment to mitochondria [22]. IPC has been
shown to involve opening of the mitochondrial permeability
transition pore [23], and we have demonstrated a role for the
permeability transition pore in mediating mitophagy in starved HL-
1 cells [24]. For these reasons, we sought to determine if Parkin
plays a role in IPC-induced cardioprotection. Here we demonstrate
that Parkin mediates cardioprotection through p62 and mitophagy.
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All procedures involving mice were approved by the Animal
Care and Use Committee at San Diego State University under
Animal Protocol number 09-10-032G, and conform to the Guide
for the Care and Use of Laboratory Animals.
Cell Culture
HL-1 cardiomyocytes were maintained in Claycomb media
(Sigma-SAFC Biosciences) as described previously [25]. MEF
ATG5
+/+ and ATG5
2/2 cells obtained from RIKEN (Dr.
Mizushima) [26] were maintained in DMEM (Invitrogen-Gibco).
Figure 1. Parkin redistributes to mitochondria in cardiomyocytes subjected to simulated ischemia (sI). A. HL-1 cells were subjected to
simulated ischemia (ischemia-mimetic buffer and hypoxia) for the indicated time, then fractionated to yield cytosol and heavy membranes (mitochondria-
enriched fraction). Right-handpanel shows Parkin in theheavy membrane fractionunder basal conditions (CON) andafter 30 min of simulated ischemia (sI
30). B. Neonatal rat ventricular cardiomyocytes were subjected to simulated ischemia, then fractionated to yield crude cytosol and heavy membrane
fractions. Right-hand panel shows Parkin in theheavy membrane fractionunder resting conditions (CON) andafter 20 min sI.C. HL-1 cells transfected with
mCherry-Parkin (red) were subjected to 30 min sI, then fixed and immunolabeled with mitochondrial marker Tom70 (green). Yellow line indicates the
segmentusedforpseudo-linescananalysis.Boxesindicateregionsenlargedatright.Imagesarerepresentativeof5independentreplicates.D.Pseudo-line-
scan tracing indicates distribution of mitochondria (Tom70, solid green line) and mCherry-Parkin (dotted red line).
doi:10.1371/journal.pone.0020975.g001
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Transfections and gene silencing were performed using
Effectene (Qiagen) according to the manufacturer’s recommenda-
tion. Cells were transfected with mCherry-Parkin in Effectene for
4 hr, then used for experiments 18 hr later. p62 (sc-36108) and
control scrambled (sc-37007) silencing complexes (100 nM)
obtained from Santa Cruz Biotechnology were transiently
transfected into HL-1 cardiomyocytes for 6 hr. After 36 hr, cells
were harvested and post nuclear supernatants were analyzed by
Western blot to confirm knockdown of p62. Parallel cell cultures
were then subjected to simulated ischemia and compared to
controls.
In Vitro Simulated Ischemia
Cells were subjected to ischemia-mimetic solution containing [in
mM: NaCl 125, KCl 8, 2-deoxyglucose 20, Na-Lactate 0.5,
MgSO4 1.25, CaCl2 1.25, KH2PO4 1.2, NaHCO3 6.25, HEPES
20 (pH 7.4)]. Culture dishes were then placed into an anaerobic
gas generating pouch system (Becton Dickson) which was then
depleted of oxygen by forcing in a mixture of carbon dioxide and
nitrogen (1:19) before being sealed. Culture dishes undergoing
simulated ischemia were incubated at 37uC for the indicated time
before harvesting. Reperfusion media used was Krebs-Ringer
Bicarbonate Buffer (Sigma K4002-1L) supplemented to [in mM:,
NaHCO3 25, CaCl2 1, HEPES 10 (pH 7.4)].
Cytotoxicity Assay
Media collected from cells after 60 min reperfusion were
assayed for LDH release using the Tox7 In Vitro Toxicology
Assay Kit (Sigma) according to the manufacturer’s instructions.
Results were normalized to the total LDH for each sample after
cells were lysed.
In Vivo Ischemic Preconditioning (IPC), Ischemia/
Reperfusion and Infarct Size Measurement
Parkin (Park2) gene knockout mice (Parkin
2/2) and control
C57BL/6J mice were purchased from Jackson Laboratories.
Coronary occlusion was performed as described previously [27].
Briefly, 10–12 week old Parkin knockout and control mice were
anesthetized with an i.p. injection of ketamine (10 mg/kg) and
xylazine (1 mg/kg). Isoflurane anesthesia was used throughout the
procedure. Pressure-controlled ventilation (Harvard Apparatus)
was maintained at a rate of 140 bpm and a pressure of 9 cm H2O.
To induce IPC, a PE-10 tube was placed on the surface of the left
anterior descending artery (LAD) which was ligated together with
an 8-0 silk suture for 3 minutes followed by 3 minutes reperfusion
for 3 cycles. For biochemical studies, hearts were excised
immediately after IPC and put in cold PBS. Risk area of infarction
was dissected out and frozen in liquid nitrogen. Sham-operated
mice had a suture placed around the LAD that was not tightened
for the length of the procedure. For infarct size determination,
hearts were subjected to 20 minutes ischemia with or without IPC.
The suture was released but left in position, and after verifying
adequate reperfusion, the chest was closed and the mice were
allowed to recover for 22 hr. Sham-operated mice were handled in
parallel. After 22 hr, mice were anesthetized, the chest re-opened,
and the hearts were injected with 1% Evans Blue and then
harvested. Transverse 1 mm thick slices of the ventricles were
stained in 1% triphenyltetrazolium chloride (Sigma).
Langendorff Perfusion
The isolated perfused rat heart model was previously described
[28]. In brief, after anesthesia and heparinization (pentobarbital
sodium 60 mg/kg i.p. and heparin 500 U i.p.), rat hearts were
excised into ice cold Krebs-Henseleit solution (in mM: NaCl
118.5 mM, KCl 4.7, KH2PO4 1.18, MgSO4 1.18, NaHCO3 25,
glucose 11.1, CaCl2 2.5) and perfused with oxygenated buffer at
constant pressure (60 mmHg) for 5 min and then subjected to IPC
for 3 cycles of 5 minutes ischemia alternating with 5 minutes
reperfusion. Hearts were further subjected to ischemia and
Figure 2. Parkin translocates in response to IPC in rat hearts. A.
Under resting conditions, Parkin is restricted to cytosol in the heart. B.
Langendorff-perfused rat hearts were subjected to continuous perfu-
sion (CON) or 3 cycles of 5 min global no-flow ischemia alternating with
5 min reperfusion (IPC). Immediately after the third 5 min reperfusion,
hearts were homogenized and fractionated to yield crude cytosol and
heavy membrane fractions which were probed for Parkin. C.
Quantification of Parkin in mitochondrial fractions from CON and IPC
hearts is shown (*p,0.05, n=4).
doi:10.1371/journal.pone.0020975.g002
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PLoS ONE | www.plosone.org 3 June 2011 | Volume 6 | Issue 6 | e20975Figure 3. IPC triggers Parkin translocation to mitochondria in vivo. A. Mice were subjected to IPC consisting of 3 cycles of 5 min coronary
artery ligation alternating with 5 min reperfusion. Heavy membrane fractions prepared from heart were probed for Parkin. Cytochrome oxidase
subunit III (COX3) was used to normalize mitochondrial loading. B. Quantification of Parkin translocation to mitochondria is shown (*p,0.05, n=5).
C. Mice were subjected to 3 cycles of IPC in vivo. Cryosections of hearts were examined to visualize Parkin translocation to mitochondria by
immunolabeling with antibodies to Tom70 (green) and Parkin (red). White line indicates segment used for pseudo-line scan analysis. Representative
images from the risk zone of sham-operated (CON) and preconditioned (IPC) hearts are shown. D. Pseudo-line scan analysis of mitochondria (Tom70,
solid green line) and endogenous Parkin (dotted red line) in cryosections from control (CON) and preconditioned (IPC) mouse hearts demonstrates
translocation of Parkin to the mitochondria after IPC.
doi:10.1371/journal.pone.0020975.g003
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and immediately frozen in liquid nitrogen for later study.
Isolation of Mitochondria
Cell Fractionation. Cells were harvested in (sucrose
homogenization buffer containing (in mM): sucrose 250, EDTA
1, HEPES 10, pH 7.4 and freshly added Protease Inhibitor
Cocktail Complete (Roche)). Cells were then disrupted by
forcefully passing cells through a 27.5 gauge syringe four times
in a microfuge tube. Mixtures were then spun at 600g for
5 minutes to eliminate the nuclear fraction and unbroken cells.
Supernatants were then spun at 7000g for 10 minutes. Pellets were
resuspended in homogenization buffer and centrifuged at 7000g
for 10 min to obtain the final mitochondria-enriched pellet (heavy
membrane fraction). Pellets were resuspended in homogenization
buffer supplemented with 1% Triton X-100. Tissue Fractionation:
Frozen heart samples were thawed on ice in MS buffer containing
(in mM: mannitol 220, sucrose 70, EGTA 2, MOPS 5, pH 7.4,
and freshly added Protease Inhibitor Cocktail Complete (Roche)).
The tissue was then minced and homogenized by Polytron
(Kinematica, Basel, Switzerland) on ice for 3 cycles of 15 s. The
homogenates were centrifuged at 1000g for 10 min at 4uC, and the
crude supernatants were further centrifuged at 3,000g for 15 min
at 4uC. The mitochondria-enriched pellet was designated as heavy
membrane fraction and the supernatant as crude cytosol. Samples
were stored at 280uC until use.
Immunofluorescence
Cells. Cells cultured in 35 mm glass bottom dishes (Mat-Tek)
were fixed with 4% paraformaldehyde for 10 min then washed
with 16 PBS 3 times 5 min. Cells were then blocked/
permeabilized for 15 min in Tris-buffered saline (TBS)(in mM:
NaCl 150, Tris-HCl 100, pH 7.4) supplemented with 5% horse
serum, 5% goat serum, 0.2% BSA and 0.3% Triton X-100. After
Figure 4. FCCP induces Parkin translocation to mitochondria in HL-1 cardiomyocytes and mitochondrial fractions in Langendorff-
perfused rat hearts. A. HL-1 cardiomyocytes were treated with the mitochondrial uncoupler FCCP (10 mM) or vehicle (ethanol, CON) for 1 hour,
then fixed and immunolabeled for Tom70 (green) and Parkin (red). Boxes outline fields that were enlarged (at right) to show details of mitochondrial
structure and colocalization. B. Cells were then scored for significant colocalization. Over 100 cells from sequential fields were assessed for each
group (*p,0.03, n=4). C. Isolated rat hearts were subjected to continuous perfusion with 100 nM FCCP or vehicle (ethanol, CON) for 5 minutes after
stabilization with KHB. Mitochondrial fractions were probed for Parkin. D. Quantification of Parkin in mitochondrial fractions from CON and FCCP
treated hearts (*p,0.05, n=4).
doi:10.1371/journal.pone.0020975.g004
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1:200 anti-Tom70 polyclonal rabbit antibody (Calbiochem), 1:200
anti-Parkin mouse monoclonal antibody (SCBT), 1:200 anti-p62
rabbit polyclonal antibody (MBL), or 1:200 anti-COX4 mouse
monoclonal (Invitrogen). After 365 min washes with TBS, cells
were incubated with either anti-rabbit AlexaFluor-488-conjugated
(Invitrogen), anti-rabbit AlexaFluor-594-conjugated (Invitrogen),
or anti-mouse Texas Red-conjugated (Abcam) secondary
antibodies for 30 min at room temperature in the dark. Cells
were washed again as described above, and stored at 4uC in the
dark immersed in 16 PBS. Tissues: Hearts were embedded in
Optimal Cutting Temperature compound, and 7 mm frozen
sections were prepared. For immunostaining, tissue sections were
immersed in acetone for 10 min at room temperature and then
allowed to air dry for 10 min. Samples were incubated in TBS
supplemented with 5% horse serum, 5% goat serum, and 0.3%
Triton X-100 for 20 min, and then incubated for 2 hr with
primary antibody (1:200 anti-Parkin from SCBT and 1:500 anti-
Tom70 from Calbiochem), followed by washing and staining with
the appropriate fluorescent secondary antibodies. Cells and
stained tissue sections were imaged on a Nikon TE300
fluorescence microscope equipped with a cooled charge-coupled
Figure 5. p62 translocates to mitochondria in HL-1 cells subjected to simulated ischemia (sI). A. HL-1 cells were subjected to sI for 30 or
60 min, then fixed and immunolabeled for Tom70 (green) and p62 (red). Boxes outline fields that were enlarged (at right) to show details of
mitochondrial structure and colocalization. B. p62 Western blot of mitochondrial fractions from HL-1 cardiomyocytes subjected to 60 min sI. C.
Quantification of Western blots is shown (Student’s T-test: *p,0.02, n=3).
doi:10.1371/journal.pone.0020975.g005
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was performed using Autodeblur Software. Colocalization,
correlation, and quantitation were performed using ImageJ
software (NIH).
Western Blot Analysis
Sample proteins from experiments were quantified using the
Bio-Rad protein assay kit. Equal amounts of protein were then
resolved on 10–20% Tris-Glycine SDS-PAGE gels (Invitrogen)
and transferred to nitrocellulose membranes. The membranes
were blocked with 5% nonfat dry milk for 1 hr then incubated
with 1:500–1:1000 diluted primary antibodies against Tom70
(Calbiochem), p62 (BD), actin (Sigma), Parkin (SCBT), or COX3
(Molecular Probes) at 4uC overnight. Membranes were washed
with TBS buffer with 1% Triton X-100 at room temperature and
incubated with appropriate peroxidase-conjugated secondary
antibodies (1:2,500). Blots were developed with SuperSignal West
Dura Extended Duration Substrate (Thermo-Pierce), and immu-
noreactive bands were visualized using the ChemiDoc XRS
system (Bio-Rad). Densitometry was performed using ImageJ
software.
Statistical Analysis
Student’s T-Test was used to determine statistical significance
with p values less than 0.05 accepted as significant. Error bars
indicate STDEV. ANOVA was used as indicated for multiple
group analysis with error bars indicating SEM.
Results
Parkin translocates to mitochondria in response to
simulated ischemia
Our previous work demonstrated a role for autophagy in the
cardioprotection afforded by ischemic preconditioning (IPC) [29].
Mitochondria are one target of autophagy, and a number of
groups have shown that Parkin is important for mitophagy in
Figure 6. Translocation of p62 to mitochondria is induced by IPC. A. Cryosectioned hearts from WT mice sham operated (CON) or subject to
IPC were immunolabeled for p62 and Tom70. Colocalization was assessed via PDM value images using Image J software where high colocalization
scores are shown in green. B. WT and Parkin
2/2 (KO) mice were subjected to sham surgery (CON) or IPC, and mitochondria were probed for p62 and
normalized to Tom70. C. Quantification of p62 translocation is shown (*p,0.05, n=5).
doi:10.1371/journal.pone.0020975.g006
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PLoS ONE | www.plosone.org 7 June 2011 | Volume 6 | Issue 6 | e20975Figure 7. Depletion of p62 attenuates sI-induced mitochondrial loss. A. HL-1 cells were treated with scrambled siRNA (siControl) or siRNA
corresponding to p62 (sip62) and labeled with antibodies to Tom70 (green) and p62 (red). B. HL-1 cells treated with siRNA were subjected to sI for
60 min and mitochondrial mass was quantified by fluorescence intensity of the mitochondrial marker Tom70. Over 100 cells were assessed for each
group and the experiment was performed 3 times. Error bars represent SEM of the 3 experiments (ANOVA: *p,0.001, **p,0.05, ***p,0.005). C.
Shown is a representative deconvolved image of HL-1 cells transfected with mCherry-Parkin (red) and subjected to sI for 30 min and probed for
Tom70 (green). D. Mitochondrial content in mCherry-Parkin-transfected cells was assessed by fluorescence intensity of Tom70, and the percentage of
cells showing substantial mitochondrial loss (similar to the cell depicted here in the center of the field) was scored for non-ischemic cells (CON) and
time points of 15, 30 and 45 min of simulated ischemia. A minimum of 100 transfected cells were scored for each time point (ANOVA: *p,0.01,
**p,0.001 versus CON, n=4). Error bars represent SEM of the 4 experiments. E. Mitochondrial content per cell was assessed in HL-1 cardiomyocytes
Parkin Mediates Mitophagy in Cardioprotection
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assessed, although cardiac expression of Parkin has been described
[11]. Under resting conditions, Parkin was present in the cytosol in
HL-1 cells and neonatal rat cardiomyocytes. However, in response
to the stress of simulated ischemia (sI), endogenous Parkin
translocated to mitochondria (Fig. 1A and B).
To further investigate the redistribution of Parkin, we transected
HL-1 cells with mCherry-Parkin and assessed its colocalization
with mitochondria before and after sI (Fig. 1C). Pseudo-line scan
analysis confirmed that mCherry-Parkin translocated to mito-
chondria after sI (Fig. 1D). Mitochondrial fragmentation was also
apparent after sI; notably, Parkin was associated with only a subset
of mitochondria (Fig. 1C, insets).
Parkin translocates to mitochondria in response to
ischemic preconditioning
We next sought to determine if Parkin translocated to
mitochondria in response to IPC. Under resting conditions,
Parkin was detected only in the crude cytosol fraction (Fig. 2A).
Langendorff-perfused rat hearts subjected to continuous perfu-
sion or 3 cycles of 5 min global no-flow ischemia alternating with
5 min reperfusion were homogenized to yield heavy membrane
and crude cytosol fractions. Western blotting revealed Parkin
translocation to the heavy membrane fraction (Fig. 2B and C).
These findings were further confirmed in vivo in mice subjected
to IPC by western blot analysis of cytosol and mitochondria
(Fig. 3A and B). We also verified Parkin translocation by
immunofluorescence microscopy of cryosections of heart tissue
(Fig. 3C). While distribution of Parkin was non-specific in sham-
operated hearts, IPC induced redistribution of Parkin to
mitochondria, as assessed by pseudo-line scan colocalization
analysis of deconvolved images (Fig. 3D). Taken together, these
results indicate that Parkin translocates to mitochondria in
response to ischemic preconditioning.
Parkin translocates to depolarized mitochondria
Parkin translocates to depolarized mitochondria [6,30]. Mito-
chondrial depolarization has been implicated as a mechanism of
cardioprotection mediated by diazoxide [31] and low-dose FCCP
[32]. We confirmed that FCCP induced Parkin translocation in
HL-1 cells exposed to 10 mM FCCP or vehicle for 1 hr (Fig. 4A
and B). To determine if low-dose FCCP mediated Parkin
translocation in the heart, we perfused rat hearts in Langendorff
mode with 10 nM FCCP or vehicle for 5 min, and assessed Parkin
distribution in cytosol and mitochondrial fractions (Fig. 4C and
D). In cells and perfused hearts, mitochondrial depolarization after
FCCP triggered translocation of Parkin to mitochondria.
Ischemia/IPC-induced p62 translocation to the
mitochondria is dependent on Parkin
Previous studies have demonstrated that p62 recognizes and
binds ubiquitinated proteins and recruits autophagosomes via its
LC3-binding domain [33]. In HL-1 cells and neonatal
cardiomyocytes, we observed that p62 translocated to the
mitochondria in response to simulated ischemia of 30 and
60 min. This was demonstrated by immunofluorescence
(Fig. 5A)a n db yW e s t e r nb l o t t i n go f subcellular fractions
(Fig. 5B and C). To determine if Parkin is important in vivo for
IPC-induced p62 recruitment to the mitochondria, we assessed
p62 translocation after IPC in wild type and Parkin knockout
mice. Following IPC, p62 translocation to the mitochondria
increased in the hearts of wild type mice, but not in Parkin
knockout mice, based on immunolabeling of cryosections with
colocalization analysis (Fig. 6A) and immunoblot analysis of
heavy membrane fractions (Fig. 6B and C). These data
s t r o n g l ys u g g e s tt h a tP a r k i ni s essential for mitochondrial
translocation of p62 in response to ischemic stress or IPC.
Parkin and p62 mediate mitophagy in response to
ischemic stress
Mitochondria are a frequent target of autophagy. To determine
the effects of simulated ischemia on mitochondrial loss, mitochon-
drial content was compared in HL-1 cells treated with siRNA to
downregulate p62/SQSTM1 or a control siRNA. Simulated
ischemia resulted in substantial mitochondrial loss which was
attenuated when p62 was downregulated (Fig. 7A and B). HL-1
cells were transfected with mCherry-Parkin and subjected to
simulated ischemia for 15–45 min. The percentage of cells
showing mitochondrial depletion increased with the duration of
simulated ischemia and was much more pronounced in the
mCherry-Parkin-expressing cells (Fig. 7C–F). However, mito-
phagy was not simply an artifact of overexpression of mCherry-
Parkin, as mitochondrial content per cell also diminished in non-
transfected cells subjected to simulated ischemia. To determine if
the disappearance of mitochondria was a consequence of
mitochondrial outer membrane degradation, we repeated the
experiments using an antibody to COX4 (Fig. 7E and F). We saw
a consistent reduction in both mitochondrial antigens in Parkin-
transfected cells.
In order to determine if the mitochondrial loss observed
following simulated ischemia is an autophagy-mediated process,
we employed the use of Atg5
2/2 MEFs. Previous studies have
shown that the ability of Atg5
2/2 MEFs to induce autophagy is
severely blunted [34]. Indeed, following 30 min of simulated
ischemia, wild-type MEFs exhibited a marked increase in the
percentage of cells that had lost significant mitochondrial mass;
similarly, the average mitochondrial content per cell was
unchanged after simulated ischemia in the Atg5
2/2 MEFs
(Fig. 8A and B). Combined, these results strongly suggest that
Parkin and p62 play an essential role ischemia-induced mitophagy.
Parkin protects myocytes against ischemia/reperfusion
injury
Having established the requirement for autophagy in IPC, and
having demonstrated the pivotal role of Parkin in mediating
mitophagy in response to ischemic stress, we sought to determine if
Parkin plays a protective role. We used siRNA to downregulate
Parkin in HL-1 cardiomyocytes (Fig. 9A) and subjected them to
60 min simulated ischemia and 60 min reperfusion (sI/R). Parkin
knockdown significantly increased the extent of cell death after sI/
R, as assessed by LDH release (Fig. 9B). In contrast, 30 min
simulated ischemia was not associated with LDH release (data not
shown), but was sufficient to induce a protected state when
followed by the 60 min index ischemia and reperfusion, as
indicated by attenuated LDH release (Fig. 9C).
subjected to 60 min of sI. The total amount of green (Tom70, outer mitochondrial membrane marker), and red (COX4, inner mitochondrial membrane
marker) fluorescence intensity per unit area within each cell were measured (ImageJ). F. For each condition, 100 cells were scored in sequential fields
(*p,0.01, n=4).
doi:10.1371/journal.pone.0020975.g007
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PLoS ONE | www.plosone.org 9 June 2011 | Volume 6 | Issue 6 | e20975Figure 8. Autophagy is necessary for selective mitochondrial loss mediated by Parkin after simulated ischemia. A. MEFs from ATG5
+/+
and ATG5
2/2 mice were transfected with mCherry-Parkin (red) and then subjected to 30 min sI. After fixation, mitochondria were visualized with
antibodies to Tom70 (green). Representative deconvolved images are shown. B. Mitochondrial depletion was quantified in a minimum of 50
mCherry-Parkin expressing cells per condition (*p,0.01, n=4).
doi:10.1371/journal.pone.0020975.g008
Parkin Mediates Mitophagy in Cardioprotection
PLoS ONE | www.plosone.org 10 June 2011 | Volume 6 | Issue 6 | e20975To determine whether Parkin is required for cardioprotection
by IPC in vivo, we subjected Parkin knockout mice to IPC, followed
by ischemia/reperfusion and determination of infarct size.
Ablation of Parkin abolished IPC-induced cardioprotection
(Fig. 10), thus revealing the important role of Parkin in
cardioprotection by IPC.
Discussion
Parkin has been shown to play a central role in mitochondrial
quality control in the brain, but its role in heart has not been
examined to date, although both organs consist of long-lived cells
with a high mitochondrial content. Because we have previously
Figure 9. Parkin mediates cytoprotection in HL-1 cells subject-
ed to simulated ischemia and reperfusion (sI/R). A. HL-1 cells
were treated with siRNA for Parkin or control siRNA and lysates were
probed for Parkin protein. Equal protein loading is shown by blotting
for actin. B. Cells treated with siRNA were subjected to sI/R (60 min
simulated ischemia and 60 min reperfusion) and cell death was
determined by measuring LDH release into the culture medium
(Student’s T-Test: *p,0.05, **p,0.001, n=6). C. HL-1 cells were
incubated in normal media for 60 min, subjected to sI/R, or
preconditioned (PreC) with 30 min sI and 60 min recovery in normal
media before being subjected to sI/R. Cell culture supernatants during
the final 60 min reperfusion were assayed for LDH release to determine
cell death. (*p,0.005, and **p,0.01, n=3).
doi:10.1371/journal.pone.0020975.g009
Figure 10. Parkin is required for IPC. A. WT and Parkin
2/2 (KO)
mice were subjected to sham treatment (CON) or IPC, followed by
20 min ischemia and 22 hr reperfusion. Area at risk was determined by
Evan’s blue injection after re-occlusion and showed no difference
between groups. B. Infarct size was determined by TTC staining and
reported as % of the area at risk. IPC reduced infarct size in WT mice but
not in Parkin KO mice (*p,0.05, n=6). Representative heart slices are
shown.
doi:10.1371/journal.pone.0020975.g010
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PLoS ONE | www.plosone.org 11 June 2011 | Volume 6 | Issue 6 | e20975shown a role for autophagy in cardioprotection by IPC, we
considered whether mitochondria were an important target of
autophagy; in particular, we considered whether Parkin might play
an important role in mitophagy in the setting of IPC. The results
presented herein reveal an important role for Parkin and p62 in
mediating mitophagy in response to ischemic stress in HL-1 cells,
and in mediating IPC-dependent cardioprotection in vivo.
Studies dating back to the 1970s have described the occurrence
of mitochondria in autophagosomes in heart tissue [35,36]. More
recently, the mitochondrial permeability transition pore has been
implicated in signaling autophagy [37], but the mechanism by
which cardiac mitochondria might be targeted for selective
removal has not been elucidated. We have shown that HL-1 cells
undergo cyclophilin D-dependent mitophagy in response to
starvation [24], but this is the first study to examine the processes
mediating mitophagy in response to ischemic stress in the heart.
Why would removal of mitochondria be beneficial? Selective
removal of the mitochondria with the lowest threshold for opening
of the mitochondrial permeability transition pore (MPTP) would
leave behind a population of robust mitochondria better-equipped
to resist ischemic stress. Since depolarized mitochondria will
hydrolyze ATP in a futile effort to restore membrane potential,
elimination of these mitochondria would actually result in
increased ATP content after I/R despite the reduced numbers
of mitochondria. Selective removal of damaged mitochondria
might also reduce the production of reactive oxygen species
(ROS). Although we did not measure ROS production in this
study, we previously reported that sulfaphenazole attenuates ROS
production and protects the heart via autophagy, and that
stimulation of autophagy attenuates ROS production by HL-1
cells exposed to lipopolysaccharide [38,39].
The limitations of this study are that we have not measured
PINK1, the mitochondrial outer membrane kinase that is
stabilized as membrane potential decreases, nor have we measured
mitochondrial membrane potential concurrently with Parkin or
p62 translocation. We saw a consistent reduction in both
mitochondrial antigens in Parkin-transfected cells. Although the
magnitude of reduction was greater for Tom70 than COX4, the
immunostaining for COX4 was done on a different set of cells,
non-concurrently. Further work will be needed to determine if
outer membrane and inner membrane antigens disappear
concurrently—consistent with organellar destruction—or if outer
membrane proteins are selectively degraded as suggested by Chan
et al. [40]. We expect that mitophagy is selective and self-limited
since the process is restricted to depolarized mitochondria [41,42].
Global depolarization of mitochondria with an uncoupler such as
FCCP is known to trigger generalized mitophagy and extensive
loss of mitochondria [43]. Cells that eliminate mitochondria will
need to replace them in order to fully restore ATP production
capacity. Thus it will be important to assess mitochondrial
biogenesis in future studies. Since biogenesis likely counterbalances
mitophagy, it will be important to develop better methods to
measure mitochondrial turnover in vivo.
The evidence presented in this study indicates that Parkin
triggers mitophagy and mediates cytoprotection in HL-1 cells
subjected to ischemic stress. These findings, coupled with the fact
that IPC is abolished in Parkin knockout mice, lead us to conclude
that Parkin mediates IPC through ubiquitination of mitochondrial
membrane proteins and recruitment of p62 to facilitate autophagic
engulfment of the decorated mitochondria.
The autophagic removal of depolarized mitochondria mediated
by Parkin and p62 may represent an important element of
mitochondrial quality control. Loss-of-function mutations of
Parkin are linked to some cases of Parkinson Disease and are
associated with mitochondrial dysfunction [44,45]. While the role
of Parkin in the heart is as yet unknown, it is interesting to note
that the incidence of heart failure and coronary artery disease is
doubled in elderly patients with Parkinson Disease compared to
age-matched peers [46].
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